Fig. 3From: Targeted delivery of immuno-RNase may improve cancer therapyHO-8910PM cells were cultured in 0.4 µmol/L ONC-V3 for 48 h. a Blank control, b–h 0.05, 0.10, 0.20, 0.40, 0.80, 1.60, 3.20 μmol/L ONC-V3, i 5-FU. The apoptotic cells increased along with the dose. This indicated that ONC-V3 could induce apoptosis in the cancer cellsBack to article page